NVCA executive calls biotech one bright spot in “otherwise sleepy” IPO market
Citing biotechnology as the one bright spot. the President and Chief Executive Officer of the National Venture Capital Association describes the initial public offering market as “otherwise sleepy” for venture fund-backed entities. Read his views and citations here.